Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 1
2012 2
2013 10
2014 19
2015 27
2016 22
2017 11
2018 9
2019 14
2020 9
2021 4
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Vilanterol.
[No authors listed] [No authors listed] 2021 Jul 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jul 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999792 Free Books & Documents. Review.
Although no published data exist on the use of vilanterol during lactation, data from the related drug, terbutaline, indicate that very little is expected to be excreted into breastmilk.[1] Vilanterol is available only in combination products such as Breo Ellipta an …
Although no published data exist on the use of vilanterol during lactation, data from the related drug, terbutaline, indicate that ve …
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Ismaila AS, Haeussler K, Czira A, Youn JH, Malmenäs M, Risebrough NA, Agarwal J, Nassim M, Sharma R, Compton C, Vogelmeier CF, Han MK, Halpin DMG. Ismaila AS, et al. Adv Ther. 2022 Sep;39(9):3957-3978. doi: 10.1007/s12325-022-02231-0. Epub 2022 Jul 17. Adv Ther. 2022. PMID: 35849317 Free PMC article. Review.
This network meta-analysis (NMA) investigated the comparative efficacy of single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus any triple (ICS/LABA/LAMA) combinations and dual therapies in patients with COPD. ...
This network meta-analysis (NMA) investigated the comparative efficacy of single-inhaler fluticasone furoate/umeclidinium/vilanterol …
Vilanterol trifenatate for the treatment of COPD.
Malerba M, Radaeli A, Montuschi P, Morjaria JB. Malerba M, et al. Expert Rev Respir Med. 2016 Jul;10(7):719-31. doi: 10.1080/17476348.2016.1184976. Epub 2016 May 25. Expert Rev Respir Med. 2016. PMID: 27143334 Review.
Vilanterol combined in fixed-dose treatments has been tested in numerous clinical trials involving thousands of patients. ...This paper will review the clinical and experimental data regarding vilanterol use in the regular treatment of COPD as well as provide a crit …
Vilanterol combined in fixed-dose treatments has been tested in numerous clinical trials involving thousands of patients. ...This pap …
Umeclidinium Bromide/Vilanterol Trifenatate (Anoro Ellipta).
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. PMID: 30212060 Free Books & Documents. Review.
The objective of this review is to evaluate the beneficial and harmful effects of umeclidinium plus vilanterol (UMEC/VI) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema....
The objective of this review is to evaluate the beneficial and harmful effects of umeclidinium plus vilanterol (UMEC/VI) for the main …
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
Ismaila AS, Haeussler K, Czira A, Tongbram V, Malmenäs M, Agarwal J, Nassim M, Živković-Gojović M, Shen Y, Dong X, Duarte M, Compton C, Vogelmeier CF, Halpin DMG. Ismaila AS, et al. Adv Ther. 2022 Nov;39(11):4961-5010. doi: 10.1007/s12325-022-02234-x. Epub 2022 Jul 20. Adv Ther. 2022. PMID: 35857184 Free PMC article.
This systematic literature review and network meta-analysis (NMA) compared the efficacy of umeclidinium/vilanterol (UMEC/VI) versus other dual and mono-bronchodilator therapies in symptomatic patients with COPD. ...Only a few clinical trials have compared different LAMA/LA …
This systematic literature review and network meta-analysis (NMA) compared the efficacy of umeclidinium/vilanterol (UMEC/VI) versus o …
Umeclidinium bromide/with vilanterol.
[No authors listed] [No authors listed] Aust Prescr. 2015 Apr;38(2):69-71. doi: 10.18773/austprescr.2015.027. Epub 2014 Dec 19. Aust Prescr. 2015. PMID: 26648622 Free PMC article. Review. No abstract available.
Vilanterol and fluticasone furoate for asthma.
Dwan K, Milan SJ, Bax L, Walters N, Powell C. Dwan K, et al. Cochrane Database Syst Rev. 2016 Sep 1;9(9):CD010758. doi: 10.1002/14651858.CD010758.pub2. Cochrane Database Syst Rev. 2016. PMID: 27582089 Free PMC article. Review.
BACKGROUND: Vilanterol (VI) is a long-acting beta(2)-agonist (LABA) that binds to the beta(2)-adrenoceptor on the airway smooth muscle, producing bronchodilation. ...
BACKGROUND: Vilanterol (VI) is a long-acting beta(2)-agonist (LABA) that binds to the beta(2)-adrenoceptor on the airway smooth muscl …
Fluticasone furoate/vilanterol: a review of its use in patients with asthma.
Syed YY. Syed YY. Drugs. 2015 Mar;75(4):407-18. doi: 10.1007/s40265-015-0354-5. Drugs. 2015. PMID: 25648266 Review.
The tolerability profile of fluticasone furoate/vilanterol was generally similar to that of fluticasone propionate/salmeterol. Thus, fluticasone furoate/vilanterol is an effective and generally well tolerated ICS/LABA option for the treatment of uncontrolled asthma. …
The tolerability profile of fluticasone furoate/vilanterol was generally similar to that of fluticasone propionate/salmeterol. Thus, …
Umeclidinium/vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease.
Blair HA, Deeks ED. Blair HA, et al. Drugs. 2015 Jan;75(1):61-74. doi: 10.1007/s40265-014-0326-1. Drugs. 2015. PMID: 25398674 Review.
Umeclidinium/vilanterol (Anoro() Ellipta; Laventair) is an inhaled fixed-dose combination of a long-acting muscarinic receptor antagonist and a long-acting beta2-adrenoceptor agonist. ...Umeclidinium/vilanterol improved pulmonary function to a significantly greater …
Umeclidinium/vilanterol (Anoro() Ellipta; Laventair) is an inhaled fixed-dose combination of a long-acting muscarinic receptor antago …
Fluticasone Furoate/Vilanterol (Breo Ellipta).
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov. PMID: 28121097 Free Books & Documents. Review.
The objective of this review was to perform a systematic review of the beneficial and harmful effects of fluticasone furoate/vilanterol (FF/V; Breo Ellipta) for the treatment of patients with COPD, including chronic bronchitis and/or emphysema....
The objective of this review was to perform a systematic review of the beneficial and harmful effects of fluticasone furoate/vilanterol …
116 results